Dr. Reddy’s & GRA announces termination of Avigan Pivotal Update
Study for hospitalized moderate to severe Covid patients in Kuwait Dr. Reddy’s
Dr Reddy
Dr. Reddy’s launches Succinylcholine Chloride Injection in US
Dr. Reddy’s Laboratoriesyesterday announced the launch of Succinylcholine Chloride Injection USP, 200
Dr. Reddy’s partners with Department of BIRAC for Sputnik V vaccine clinical trials in India
Dr. Reddy’s Laboratories Ltd., announced its partnership with Biotechnology Industry Research Assistance
Dr. Reddy’s Laboratories announces appointment of new Chief Financial Officer
Dr. Reddy’s Laboratories Ltd. today announced that Parag Agarwal will be joining
Dr. Reddy’s announces the re-launch of OTC Famotidine Tablets USP, 10 mg and 20 mg, store-brand equivalent of Pepcid AC in the U.S. Market
Dr. Reddy’s Laboratories Ltd. today announced the re-launch of over-the-counter (OTC) Famotidine
Dr. Reddy’s and RDIF receive approval to conduct clinical trial for Sputnik V vaccine in India
Dr. Reddy’s Laboratories Ltd. and Russian Direct Investment Fund (RDIF), Russia’s sovereign
DR. REDDY’S LABORATORIES JOINS SBTI AND SETS 2030 GHG EMISSION TARGETS
Dr. Reddy’s Laboratories Ltd. has joined the Science Based Targets initiative’s (SBTi)
DR.REDDY’S LABORATORIES ANNOUNCES THE LAUNCH OF CINACALCET TABLETS IN THE U.S. MARKET
Dr. Reddy’s Laboratories Ltd. Today announced the launch of Cinacalcet Tablets, a
Dr Reddy’s launches Avigan (Favipiravir) in India for COVID-19
Dr. Reddy’s Laboratories Ltd. today announced the launch of AVIGAN (Favipiravir) 200 mg
Dr. Reddy’s Laboratories launches drug to treat infections US market
Dr. Reddy’s Laboratories today announced the launch of Ciprofloxacin 0.3% and Dexamethasone